HIV-Associated Malignancies

Oncol Res Treat. 2017;40(3):80-81. doi: 10.1159/000456716. Epub 2017 Feb 20.

Author

Kai Hübel¹

Affiliation

¹ Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

PMID: 28273669
DOI: 10.1159/000456716

No abstract available

Publication types

Review

MeSH terms

AIDS-Related Opportunistic Infections / prevention & control
Anti-HIV Agents / adverse effects
Anti-HIV Agents / therapeutic use
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Cross-Sectional Studies
Guideline Adherence
HIV Infections / diagnosis*
HIV Infections / epidemiology
HIV Infections / pathology
HIV Infections / therapy
Humans
Lymphoma, AIDS-Related / diagnosis*
Lymphoma, AIDS-Related / epidemiology
Lymphoma, AIDS-Related / pathology
Lymphoma, AIDS-Related / therapy
Neoplasm Staging
Prognosis
Risk

Substances

Anti-HIV Agents
Antineoplastic Agents